GRIFOLS | GRF - Interest Expense On Debt



GRIFOLS reported EUR202.71M in Interest Expense on Debt for its fiscal quarter ending in June of 2024.


Interest Expense On Debt Change Date
Alcon AG USD 49M 1000K Mar/2025
Amadeus IT EUR 19.8M 2.1M Jun/2025
Amarin USD 3K 3K Dec/2024
argenx SE 1.13M 9K Jun/2025
AstraZeneca 303M 126M Jun/2025
Bayer 495M 89M Jun/2025
Demant 435M 27M Jun/2025
Ence Energia y Celulosa 11.2M 4.02M Jun/2025
Essilor EUR 147M 102.5M Jun/2025
Fresenius 86M 30M Jun/2025
Fresenius Medical Care EUR 96.58M 15.58M Jun/2025
Galapagos EUR 780K 49.34M Mar/2025
Genmab DKK 9M 4M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical 22M 9M Jun/2024
Inditex EUR 56M 297M Apr/2025
Merck 79M 1000K Jun/2025
Novartis USD 289M 19M Jun/2025
Philips 80M 24M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025
Smith & Nephew 69M 1000K Jun/2025
UCB 108M 16M Dec/2024
Viscofan 2.65M 237K Jun/2025